Finance

Lists
Why is BLRX down 5.80%?
Dive Deeper
BLRX:NASDAQ
BioLine RX Ltd - ADR
US$1.30
-5.80%
(-0.080) 1D
ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLRX...
Open
US$1.37
High
US$1.54
Low
US$1.30
Mkt. cap
9.30 ሚ
Avg. vol.
12.80 ሺ
Volume
14.11 ሺ
52-wk high
US$3.95
52-wk low
US$1.30
EPS
-US$1.77
Beta
1.64
Shares outstanding
4.98 ሚ
No. of employees
22
Open
US$1.37
High
US$1.54
Low
US$1.30
Mkt. cap
9.30 ሚ
Avg. vol.
12.80 ሺ
Volume
14.11 ሺ
52-wk high
US$3.95
52-wk low
US$1.30
EPS
-US$1.77
Beta
1.64
Shares outstanding
4.98 ሚ
No. of employees
22
News stories
From web sources and news partners
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to BLRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BLRX in the last 3 months
Highest
Current US$1.30
US$26.00 (+1,900.00%)
Average
US$26.00 (+1,900.00%)
Lowest
US$26.00 (+1,900.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
US$26.00
+1,900%
10/23/2026
Justin Walsh
JonesTrading
Buy
Reiterated
US$12.00
+823.1%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
427.00 ሺ
194.00 ሺ
477.00 ሺ
294.00 ሺ
Cost of goods sold
84.00 ሺ
40.00 ሺ
95.00 ሺ
59.00 ሺ
Cost of revenue
84.00 ሺ
40.00 ሺ
95.00 ሺ
59.00 ሺ
Research and development expenses
1.72 ሚ
2.42 ሚ
2.53 ሚ
2.94 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831.00 ሺ
1.12 ሚ
858.00 ሺ
865.00 ሺ
Operating expense
2.55 ሚ
3.54 ሚ
3.39 ሚ
3.81 ሚ
Total operating expenses
2.63 ሚ
3.58 ሚ
3.48 ሚ
3.87 ሚ
Operating income
-2.21 ሚ
-3.39 ሚ
-3.00 ሚ
-3.57 ሚ
Other non operating income
1.16 ሚ
1.10 ሚ
458.00 ሺ
-690.00 ሺ
EBT including unusual items
-977.00 ሺ
-2.24 ሚ
-2.59 ሚ
-4.34 ሚ
EBT excluding unusual items
-977.00 ሺ
-2.24 ሚ
-2.59 ሚ
-4.34 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-977.00 ሺ
-1.38 ሚ
-1.60 ሚ
-3.03 ሚ
Net profit margin
-228.81%
-713.92%
-335.64%
-1,029.25%
Earnings per share
-
-
-
-
Interest and investment income
377.00 ሺ
-
208.00 ሺ
132.00 ሺ
Interest expense
-304.00 ሺ
-288.00 ሺ
-250.00 ሺ
-208.00 ሺ
Net interest expenses
73.00 ሺ
-288.00 ሺ
-42.00 ሺ
-76.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.09 ሚ
-3.33 ሚ
-2.92 ሚ
-3.50 ሚ
Gain or loss from assets sale
-
25.00 ሺ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች